Rejuvenate Bio secures license to commercialize gene therapy for treating age-related diseases in do

Rejuvenate Bio has secured a license to commercialize a gene therapy technology developed at the Wyss Institute to treat multiple age-related diseases in dogs, which could open the door to similar treatments for humans in the future.

Thu, 06 Feb 2020 22:51:00 -0500

Increasing the number of small blood vessels may be helpful for recovering movement

Many health conditions - ranging from disease of particular organs such as heart and lungs, widespread metabolic issues such as diabetes, or following trauma such as spinal cord injury – cause difficulties with movement.

Thu, 06 Feb 2020 22:43:54 -0500

Study identifies two possible targets to halt liver damage in NASH

As much as 12 percent of adults in the United States are living with nonalcoholic steatohepatitis (NASH), an aggressive condition that can lead to cirrhosis or liver cancer.

Thu, 06 Feb 2020 17:01:56 -0500